The effect of spine mobilisation for patients with back pain and leg pai
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Lumbar RadiculopathyHealth Condition 2: G541- Lumbosacral plexus disorders
- Registration Number
- CTRI/2015/09/006165
- Lead Sponsor
- Smt Kashibai Navale College of Physiotherapy Self funding
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Unilateral LBP radiating posterolateraly to the lower leg below knee, present for more than 6 weeks
Negative LANSS
Hypoesthesia and/or lower motor neuron weakness in the affected limb
Exclusion Criteria
Contraindications to manual therapy
Abnormal bowel and bladder function
Withdrawal of informed consent
Bilateral leg pain
Upper motor neuron lesions showing exaggerated deep tendon reflexes
Previous Physiotherapy interventions for leg pain
Previous history of spinal surgery and surgery to the affected lower limb or trauma within the past 6 months
Pregnant female subjects
History of vascular disease in the lower extremities
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Leg pain intensity over last 24 hours on 100 mm horizontal visual analogue pain scale (VAS) <br/ ><br>2.Overall improvement will be measured using The 2. 2. Global Rating Of Change Scale (GROC) <br/ ><br>Timepoint: 1.at the end of 1st and 6th treatment session, then 3 months and 6 months after randomisation.
- Secondary Outcome Measures
Name Time Method 1.Intensity of LBP over last 24 hours on 100 mm horizontal visual analogue pain scale (VAS) <br/ ><br>2.A body chart for the pain location to determine the pain peripheralization or centralization. <br/ ><br>3.Lumbar spine ROM measured with bubble goniometer <br/ ><br>4.SLR test ROM measured with an inclinometer <br/ ><br>5.Functional disability measured with Oswestry Disability Index <br/ ><br>Timepoint: at the end of 1st and 6th treatment session, then 3 months and 6 months after randomisation.